慢性肝病：发病机制、检测和治疗的最新研究。
Chronic Liver Disease: Latest Research in Pathogenesis, Detection and Treatment.
机构信息
Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.
Department of Clinical and Biological Sciences, University of Turin, 10125 Turin, Italy.
出版信息
Int J Mol Sci. 2023 Jun 25;24(13):10633. doi: 10.3390/ijms241310633.
Abstract
Chronic liver disease (CLD) is a major global health threat and has emerged as a leading cause of human death [...].
摘要
慢性肝病（CLD）是一个主要的全球健康威胁，并已成为人类死亡的主要原因[... ]。
相似文献
1
Chronic Liver Disease: Latest Research in Pathogenesis, Detection and Treatment.慢性肝病：发病机制、检测和治疗的最新研究。
Int J Mol Sci. 2023 Jun 25;24(13):10633. doi: 10.3390/ijms241310633.
2
[The clinical picture, diagnosis and treatment of chronic liver diseases (a lecture)].[慢性肝病的临床表现、诊断与治疗（讲座）]
Lik Sprava. 1993 Jul(7):14-23.
3
Zinc supplementation and its benefits in the management of chronic liver disease: An in-depth literature review.锌补充剂及其在慢性肝病管理中的益处：深入文献综述。
Ann Hepatol. 2021 Nov-Dec;25:100549. doi: 10.1016/j.aohep.2021.100549. Epub 2021 Oct 3.
4
Treatment for restless legs syndrome secondary to chronic liver disease: a case report.慢性肝病继发不安腿综合征的治疗：一例报告
Intern Med. 2012;51(8):933-4. doi: 10.2169/internalmedicine.51.6853. Epub 2012 Apr 15.
5
Classification and treatment of chronic active liver disease.慢性活动性肝病的分类与治疗
Gastroenterology. 1968 Dec;55(6):724-9.
6
The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital.新加坡总医院内科治疗患者中慢性肝病对静脉血栓栓塞的影响。
Thromb Res. 2015 Sep;136(3):548-51. doi: 10.1016/j.thromres.2015.06.033. Epub 2015 Jul 6.
7
[Pathogenesis of chronic liver diseases. Thoughts on their treatment].[慢性肝病的发病机制。关于其治疗的思考]
Med Welt. 1970 Jun 27;26:1181-6.
8
Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease (Review).基质金属蛋白酶及其抑制剂作为慢性肝病炎症和纤维化的标志物（综述）
Int J Mol Med. 2009 Aug;24(2):143-52. doi: 10.3892/ijmm_00000217.
9
Management of polycystic liver disease.多囊肝病的管理
Can J Gastroenterol. 2004 Nov;18(11):666-70. doi: 10.1155/2004/947345.
10
Unexplained chronic liver disease in Ethiopia: a cross-sectional study.埃塞俄比亚不明原因的慢性肝病：一项横断面研究。
BMC Gastroenterol. 2018 Feb 13;18(1):27. doi: 10.1186/s12876-018-0755-5.
引用本文的文献
1
The Impact of Hybrid Bionanomaterials Based on Gold Nanoparticles on Liver Injury in an Experimental Model of Thioacetamide-Induced Hepatopathy.基于金纳米颗粒的杂化生物纳米材料对硫代乙酰胺诱导的肝病实验模型中肝损伤的影响
Biomolecules. 2025 Jul 24;15(8):1068. doi: 10.3390/biom15081068.
2
Cystathionine γ-lyase downregulation promotes liver injury and necroptosis through reprogramming of methionine cycle.胱硫醚γ-裂解酶的下调通过甲硫氨酸循环的重编程促进肝损伤和坏死性凋亡。
Redox Rep. 2025 Dec;30(1):2531650. doi: 10.1080/13510002.2025.2531650. Epub 2025 Jul 28.
3
Nanoparticle-based therapeutic strategies for chronic liver diseases: Advances and insights.基于纳米颗粒的慢性肝病治疗策略：进展与见解
Liver Res. 2025 Apr 12;9(2):104-117. doi: 10.1016/j.livres.2025.04.002. eCollection 2025 Jun.
4
Temporal Trends and Disparities in Chronic Liver Disease Mortality: An Analysis Using National Center for Health Statistics (NCHS) Data Ranging From 1999 to 2023.慢性肝病死亡率的时间趋势和差异：一项使用美国国家卫生统计中心（NCHS）1999年至2023年数据的分析
Cureus. 2025 May 12;17(5):e83957. doi: 10.7759/cureus.83957. eCollection 2025 May.
5
Comprehensive review of leonurine: harnessing its therapeutic potential for chronic diseases.益母草综述：挖掘其对慢性病的治疗潜力
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 9. doi: 10.1007/s00210-025-04087-x.
6
AMPK agonist AICAR ameliorates maternal hepatic lipid metabolism disorder, inflammation, and fibrosis caused by PM exposure during pregnancy.AMPK激动剂AICAR可改善孕期暴露于颗粒物所致的母体肝脏脂质代谢紊乱、炎症及纤维化。
Sci Rep. 2025 Mar 13;15(1):8689. doi: 10.1038/s41598-025-93395-6.
7
Treatment outcomes of chronic liver disease and associated factors among patients treated at hospitals in Bahir Dar city, north-west Ethiopia.埃塞俄比亚西北部巴赫达尔市医院收治的慢性肝病患者的治疗结果及相关因素
BMC Gastroenterol. 2025 Mar 6;25(1):141. doi: 10.1186/s12876-025-03719-z.
8
Advances, challenges and future applications of liver organoids in experimental regenerative medicine.肝脏类器官在实验性再生医学中的进展、挑战及未来应用
Front Med (Lausanne). 2025 Jan 24;11:1521851. doi: 10.3389/fmed.2024.1521851. eCollection 2024.
9
Neutrophil extracellular traps facilitate liver inflammation/fibrosis progression by entering macrophages and triggering AIM2 inflammasome-dependent pyroptosis.中性粒细胞胞外诱捕网通过进入巨噬细胞并触发 AIMP 炎性小体依赖性细胞焦亡来促进肝脏炎症/纤维化进展。
Cell Commun Signal. 2024 Nov 20;22(1):556. doi: 10.1186/s12964-024-01944-9.
10
Aging, ROS, and cellular senescence: a trilogy in the progression of liver fibrosis.衰老、ROS 和细胞衰老：肝纤维化进展中的三部曲。
Biogerontology. 2024 Nov 15;26(1):10. doi: 10.1007/s10522-024-10153-3.
本文引用的文献
1
The Role of Fucoxanthin in Non-Alcoholic Fatty Liver Disease.姜黄素在非酒精性脂肪性肝病中的作用。
Int J Mol Sci. 2023 May 3;24(9):8203. doi: 10.3390/ijms24098203.
2
Detection of Novel Biomarkers in Pediatric Autoimmune Hepatitis by Proteomic Profiling.通过蛋白质组学分析检测儿科自身免疫性肝炎的新型生物标志物。
Int J Mol Sci. 2023 Apr 19;24(8):7479. doi: 10.3390/ijms24087479.
3
Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients.hsa-miR-21-5p、hsa-miR-192-5p、hsa-miR-155-5p、hsa-miR-199a-5p 联合检测及其比值对 HCV 感染患者合并肝硬化的肝细胞癌的诊断意义。
Int J Mol Sci. 2023 Feb 5;24(4):3157. doi: 10.3390/ijms24043157.
4
Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病的诊治进展。
Int J Mol Sci. 2023 Feb 2;24(3):2844. doi: 10.3390/ijms24032844.
5
Inflammatory processes involved in NASH-related hepatocellular carcinoma.与 NASH 相关的肝细胞癌中的炎症过程。
Biosci Rep. 2023 Jan 31;43(1). doi: 10.1042/BSR20221271.
6
Cocaine-Induced Time-Dependent Alterations in Cytochrome P450 and Liver Function.可卡因诱导的细胞色素 P450 和肝功能的时间依赖性改变。
Int J Mol Sci. 2023 Jan 13;24(2):1632. doi: 10.3390/ijms24021632.
7
Lipid Droplet-Associated Proteins Perilipin 1 and 2: Molecular Markers of Steatosis and Microvesicular Steatotic Foci in Chronic Hepatitis C.脂滴相关蛋白 perilipin 1 和 2：慢性丙型肝炎脂肪变性和微泡性脂肪变性灶的分子标志物。
Int J Mol Sci. 2022 Dec 7;23(24):15456. doi: 10.3390/ijms232415456.
8
Emerging Role of NLRP3 Inflammasome and Pyroptosis in Liver Transplantation.NLRP3 炎性小体和细胞焦亡在肝移植中的新作用。
Int J Mol Sci. 2022 Nov 19;23(22):14396. doi: 10.3390/ijms232214396.
9
Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH).外泌体 microRNAs 与非酒精性脂肪性肝炎（NASH）的进展。
Int J Mol Sci. 2022 Nov 4;23(21):13501. doi: 10.3390/ijms232113501.
10
Hepatic Sam68 Regulates Systemic Glucose Homeostasis and Insulin Sensitivity.肝 Sam68 调节全身葡萄糖稳态和胰岛素敏感性。
Int J Mol Sci. 2022 Sep 29;23(19):11469. doi: 10.3390/ijms231911469.
Zotero 插件